Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HLG | Ann: SPH Notice - Timothy Charles Glasson | 30/06/25 | 0 | 96 | |||
|
|||||||
HLG | Ann: Directors and Officers Disclosure | 30/06/25 | 0 | 59 | |||
|
|||||||
HLG | Ann: Directors and Officers Disclosure | 30/06/25 | 0 | 88 | |||
|
|||||||
HLG | Ann: Directors and Officers Disclosure | 27/05/25 | 0 | 67 | |||
|
|||||||
HLG | Ann: Directors and Officers Disclosure | 20/05/25 | 0 | 80 | |||
|
|||||||
HLG | Ann: Directors and Officers Disclosure | 13/05/25 | 0 | 75 | |||
|
|||||||
HLG | Ann: Directors and Officers Disclosure | 06/05/25 | 0 | 93 | |||
|
|||||||
HLG | Ann: HLG Interim Report for 6 months ended 1 February 2025 | 30/04/25 | 0 | 143 | |||
|
See All Discussions